Abhishek Infraventures Share Price
9.32+0.00 (+0.00%)
+32.01% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Abhishek Infraventures Share Price
9.32+0.00 (+0.00%)
+32.01% past 1 Year
Technical meters

No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Abhishek Infraventures Share Price
9.32+0.00 (+0.00%)
+32.01% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly

No results found
Bulk & block deals

No results found
Insider trading & SAST

No results found
Abhishek Infraventures Share Price
9.32+0.00 (+0.00%)
+32.01% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Abhishek Infraventures Share Price
9.32+0.00 (+0.00%)
+32.01% past 1 Year
Corporate filings & documents

No corporate filings & documents found
Abhishek Infraventures Share Price
9.32+0.00 (+0.00%)
+32.01% past 1 Year
News
NSE Reports Rs 201.49 Crore Block Trade In BSE Shares
Equity
NSE
Premier Energies May See Block Deal at Seven to Eight Percent Discount
Equity
PREMIERENE
Mahindra Lifespaces Enters Mumbai Area Plotted Development
Equity
MAHLIFE
Aster DM Healthcare Reports Rs 70.53 Crores NSE Block Trade
Equity
ASTERDM
Gujarat Pipavav Raises FY27 EBIT Growth Outlook To 22 Percent To 26 Percent
Equity
GPPL
Gujarat Pipavav raises FY27 container volume growth forecast
Equity
GPPL
Balkrishna Industries To Introduce Passenger Car Radial Tyres In January 2027
Equity
BALKRISIND
Balkrishna Industries Targets Annual Tire Sales Of 800,000 Units
Equity
BALKRISIND
AIA Engineering Reports Rs 23.34 Crores NSE Block Trade
Equity
AIAENG
Dr. Reddy’s Receives Brazil Approval for Generic Semaglutide Injection
Equity
DRREDDY
Fabtech CFO Kalpesh Chauhan To Step Down On November 12, 2026
Equity
FABTECH
Powergrid Reports Rs 56.26 Crores NSE Block Trade
Equity
POWERGRID
DLF Records Rs 52.54 Crore NSE Block Trade At Rs 729.15
Equity
DLF
Aurobindo Expects FY28 Growth From Lannett China And Biosimilars
Equity
AUROPHARMA
Aurobindo Targets Higher Peng Production By FY28 Amid Anti Dumping Filing
Equity
AUROPHARMA
Aurobindo China Facility Expected To Break Even By Third Quarter FY2027
Equity
AUROPHARMA
Brigade Enterprises Partners With IFC For Middle Income Housing Projects
Equity
BRIGADE
Government Proposes Immediate Suspension Of Drug Manufacturing Licences
Equity
SUNPHARMA
Alembic Pharmaceuticals Receives USFDA Final Approval For Olopatadine Ophthalmic Solution
Equity
APLLTD
SVLL Reports Stronger Second Quarter EBITDA And Improved Operating Margin
Equity
SVLL

